DD-25

Fortuderm Ltd. · Phase 1 active Small molecule

At a glance

Generic name	DD-25
Also known as	Fortuderm DD-25 Psoriasis Cream
Sponsor	Fortuderm Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of DD-25 Topical Cream for the Treatment of Psoriasis Vulgaris : Proof of Concept Study (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DD-25 CI brief — competitive landscape report
DD-25 updates RSS · CI watch RSS
Fortuderm Ltd. portfolio CI